Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 1037792-44-1 Chemical Structure| 1037792-44-1

Structure of MBX-2982
CAS No.: 1037792-44-1

Chemical Structure| 1037792-44-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MBX-2982 is a selective, orally-available GPR119 agonist for the treatment of type 2 tiabetes.

Synonyms: MBX-2982

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MBX-2982

CAS No. :1037792-44-1
Formula : C22H24N8OS
M.W : 448.54
SMILES Code : CCC1=CN=C(N2CCC(C3=NC(COC4=CC=C(N5N=NN=C5)C=C4)=CS3)CC2)N=C1
Synonyms :
MBX-2982
MDL No. :MFCD22628771
InChI Key :NFTMKHWBOINJGM-UHFFFAOYSA-N
Pubchem ID :25025505

Safety of MBX-2982

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H228-H315-H319
Precautionary Statements:P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313
Class:4.1
UN#:1325
Packing Group:

Related Pathways of MBX-2982

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293 cells 10^−5M-10^−11M 30 min Measure cAMP accumulation to evaluate the activation of GPR119 by MBX-2982 PMC9671963
HepG2 cells 1-10 μM 24 h MBX-2982 inhibited sorafenib-induced LC3B II protein expression, indicating suppression of autophagosome formation. PMC6267899
MDA-MB-231 cells 1-10 μM 24 h MBX-2982 inhibited gefitinib-induced LC3B II protein expression, indicating suppression of autophagosome formation. PMC6267899
MCF-7 cells 1-10 μM 24 h MBX-2982 inhibited gefitinib-induced LC3B II protein expression, indicating suppression of autophagosome formation. PMC6267899

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Balb/c-nu mice MCF-7 xenograft model Oral 10 mg/kg 5 times a week for 40 days Combination of MBX-2982 with gefitinib significantly inhibited the growth of MCF-7 xenograft tumors. PMC6267899

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.23mL

0.45mL

0.22mL

11.15mL

2.23mL

1.11mL

22.29mL

4.46mL

2.23mL

References

 

Historical Records

Categories